Antitumor agent targeting the RAS-RAF signaling pathway; induces apoptosis by arresting cells in the G2/M phase; increases p53 and ROS levels in cancer cells, leading to elliptical and irregular nuclear morphology; exhibits tumor growth inhibitory activity in A549 xenograft models.